an increasing trendp = 0.001
Survivors demonstrated an increasing trend of GZMB in CD4+ (8.36%–9.61%, p = 0.001) and CD8+ T cells (38.2%–44.8%, p = 0.005) with elevated IL‐2 production in CD4+ T cells (4.13% versus 5.46%, p = 0.005).
Survivors demonstrated an increasing trend of GZMB in CD4+ (8.36%–9.61%, p = 0.001) and CD8+ T cells (38.2%–44.8%, p = 0.005) with elevated IL‐2 production in CD4+ T cells (4.13% versus 5.46%, p = 0.005).